K. Morita

Design and evaluation of new antipsoriatic antedrug candidates having 16-en-22-oxa-vitamin D3 structures.

M. Ohmori, A. Sugita, A. Kawase, 2006, Bioorganic & medicinal chemistry letters.

Abstracts of selected papers presented at the 29th annual meeting of the Japanese society of gastroenterology Kofu, Japan, November 5–7, 1987

A. Tangoku, M. Kusano, K. Tanikawa, 1988, Gastroenterologia Japonica.

The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic PIK3CA Mutations

Miyuki Yoshida, N. Ishii, Y. Aoki, 2011, Clinical Cancer Research.

Cancer Therapy : Preclinical The Selective Class I PI 3 K Inhibitor CH 5132799 Targets Human Cancers Harboring Oncogenic PIK 3 CA Mutations

Miyuki Yoshida, N. Ishii, Y. Aoki, 2011 .

Proceedings of the 27th Annual Meeting Matsuyama, Japan, November 7–9, 1985

M. Makuuchi, S. Futagawa, Y. Atomi, 1986, Gastroenterologia Japonica.

Preclinical evaluation of the potential for cytochrome P450 inhibition and induction of the selective ALK inhibitor, alectinib

H. Shindoh, Kenji Takanashi, M. Ishigai, 2017, Xenobiotica; the fate of foreign compounds in biological systems.

In vitro–in vivo extrapolation of metabolic clearance using human liver microsomes: factors showing variability and their normalization

Kiyomi Ito, T. Kudo, K. Morita, 2020, Xenobiotica; the fate of foreign compounds in biological systems.

Skin permeation and metabolism of a new antipsoriatic vitamin D(3) analogue of structure 16-en-22-oxa-24-carboalkoxide with low calcemic effect.

K. Sugibayashi, Y. Aso, K. Yamaguchi, 2007, International journal of pharmaceutics.